SCHEMBL27675956

SCHEMBL27675956

Clc1cccc(C2CCCCC2CCN2CCNCC2)c1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SLC6A4 P31645 7/20 0.43
▸ HTR2A P28223 3/20 0.43
▸ HTR2C P28335 3/20 0.43
▸ HTR2B P41595 3/20 0.43
▸ SIGMAR1 Q99720 3/20 0.43
▸ CYP1A2 P05177 2/20 0.43
▸ CYP2D6 P10635 2/20 0.43
▸ HTR3E A5X5Y0 1/20 0.43
▸ HTR3B O95264 1/20 0.43
▸ TP53 P04637 1/20 0.43
▸ ADRB1 P08588 1/20 0.43
▸ CYP3A4 P08684 1/20 0.43
▸ HTR1A P08908 1/20 0.43
▸ THRB P10828 1/20 0.43
▸ CYP2C9 P11712 1/20 0.43
▸ CYP2C19 P33261 1/20 0.43
▸ HTR7 P34969 1/20 0.43
▸ HTT P42858 1/20 0.43
▸ HTR3A P46098 1/20 0.43
▸ HTR6 P50406 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL27655991 0.99 HTR2A (0.42) SLC6A4HTR2AHTR2CHTR2BSIGMAR1
SCHEMBL27655958 0.98 SLC6A4 (0.43) SLC6A4HTR2AHTR2CHTR2BSIGMAR1
Hydrochloric Acid SCHEMBL27676056 0.96 HTR2A (0.42) SLC6A4HTR2AHTR2CHTR2BSIGMAR1
Hydrochloric Acid SCHEMBL27662355 0.96 HTR2A (0.42) SLC6A4HTR2AHTR2CHTR2BSIGMAR1
Hydrochloric Acid SCHEMBL27684330 0.90 HTR2A (0.40) SLC6A4HTR2AHTR2CHTR2BSIGMAR1
Hydrochloric Acid SCHEMBL27676007 0.85 MEN1 (0.47) SLC6A4HTR2AHTR2CHTR2BCCR5
Hydrochloric Acid SCHEMBL27655953 0.83 MEN1 (0.47) SLC6A4HTR2AHTR2CHTR2BCCR5
SCHEMBL27683995 0.79 HRH3 (0.47) SLC6A4HTR2AHTR2CHTR2BCCR5
SCHEMBL27671829 0.75 SOS1 (0.40) HTR2AHTR2CHTR2BALDH1A1SLC6A3
Hydrochloric Acid SCHEMBL27671839 0.74 HTR2C (0.40) SLC6A4HTR2AHTR2CHTR2BHTR1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1972920-A Arylalkyl piperazine derivatives for the treatment of conditions ameliorated by monoamine reuptake including vasomotor symptoms WYETH CORP (US) 2007-05-30 — — CN claimed
CN-1972920-A Arylalkyl piperazine derivatives for the treatment of conditions ameliorated by monoamine reuptake including vasomotor symptoms WYETH CORP (US) 2007-05-30 — — CN disclosed
CN-1894226-A Arylalkyl- and cycloalkylalkyl-piperazine derivatives and methods of their use WYETH CORP (US) 2007-01-10 — — CN disclosed
Send feedback